Owens & Minor (NYSE:OMI) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Owens & Minor (NYSE:OMI) issued its quarterly earnings results on Friday. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.53 by $0.02, Zacks reports. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.70 billion during the quarter, compared to analysts’ expectations of $2.68 billion. During the same period in the previous year, the business earned $0.69 earnings per share. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. Owens & Minor updated its FY25 guidance to $1.60-1.85 EPS and its FY 2025 guidance to 1.600-1.850 EPS.

Owens & Minor Stock Performance

Shares of Owens & Minor stock opened at $9.56 on Friday. Owens & Minor has a 52 week low of $6.07 and a 52 week high of $28.35. The business’s fifty day simple moving average is $11.51 and its 200-day simple moving average is $13.26. The firm has a market cap of $736.78 million, a PE ratio of -14.70, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11.

Wall Street Analyst Weigh In

Several analysts recently commented on OMI shares. Robert W. Baird dropped their price target on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating for the company in a research report on Tuesday. Citigroup dropped their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. UBS Group lowered their price objective on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Finally, Barclays lowered their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $14.92.

Owens & Minor declared that its Board of Directors has approved a stock buyback plan on Friday, February 28th that allows the company to repurchase $100.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 13.6% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its stock is undervalued.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.